Anulex Technologies, Inc. – Trademark Portfolio

Entity Type: 03

Anulex Technologies, Inc. holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 12 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include XCLOSE. The owner is based in Minnetonka, MN.

5600 Rowland Road, Suite 280

Minnetonka, MN 55343

12 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Anulex Technologies, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (12 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Anulex Technologies, Inc. have?

Anulex Technologies, Inc. has 12 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned, 8 cancelled.

What trademark classes does Anulex Technologies, Inc. file in?

Anulex Technologies, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Anulex Technologies, Inc.'s most well-known trademarks?

Anulex Technologies, Inc.'s registered trademark portfolio includes well-known marks such as XCLOSE. These are among 1 currently registered trademark in the portfolio.

What is Anulex Technologies, Inc.'s trademark registration success rate?

Anulex Technologies, Inc. has a 8% trademark registration rate, with 1 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.